Eikon Therapeutics closes $148M financing to develop super-resolution microscopy
Eikon Therapeutics closes $148M financing to develop super-resolution microscopy 06 May 2021 California-based firm to integrate advanced optics, machine learning with biochemistry; its target application is drug discovery. Eikon focuses on live-cell super-resolution microscopy for drug discovery.Eikon Therapeutics, a Hayward, California-based company focused on live-cell super-resolution microscopy and engineering for drug discovery, has this week announced that it has closed a $148 million Series A financing round. The funding is led by The Column Group with participation from Foresite Cap...